According to the research report titled ‘Nutrigenomics Testing Market Size By Application (Obesity, Diabetes, Cancer, Cardiovascular Diseases), By Distribution Channel (Hospitals & Clinics, Online Platform), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 - 2025’, available with Market Study Report, global nutrigenomics testing market size to reach USD 800 million by the end of the forecast period 2019-2025.
 

Growing prevalence of obesity along with advancements in genomics and molecular biology are spurring global nutrigenomics testing market growth. However, stringent regulations may impede business development in the upcoming years.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2203968/
 

For the uninitiated, nutrigenomics testing allows nutritionists to create personalized diet and exercise plan for obese people to help in weight control and adopt a healthy lifestyle. Moreover, obesity is major catalyst for chronic diseases like diabetes and cardiovascular diseases, which further raises the significance of this testing procedure.
 

Based on application scope, global nutrigenomics testing market from diabetes segment was worth USD 70 million in 2018 and is projected to accrue notable returns over the forecast timeframe. Nutritional genomics testing provides a better understanding of the patterns regarding epigenetic modifications, genetic variations, and gene diet phenotype interactions. It also unveils data on the early molecular events in diabetes, thereby preventing potential complexities and diseases progression.
 

Considering the distribution channel, hospitals and clinics segment is projected to showcase a CAGR of 10.5% CAGR through 2025. This can be attributed to higher inclination of patients towards hospitals and clinics for chronic disease treatment. Moreover, technology vendors commercialize advanced quality nutrigenomics testing kits to healthcare facilities, further boosting the segmental growth.
 

On the geographical front, Japan nutrigenomics testing market reflected 35% of the revenue share in Asia Pacific in 2018 and is touted to record significant gains over the forecast duration. Rising inclination towards personalized diet, growing prevalence of chronic diseases, favorable initiatives by industry players, and positive outlook of the startups in this field are fostering the industry growth in Japan.
 

Speaking of the competitive arena, Sanger Genomics, Xcode Life, Gene Box, Salugen Inc., Pathwa Genomics (acquired by OME Care), Metagenics Inc., NutraGene, Interleukin Genetics Inc., GX Sciences, Nutrigenomix Inc., Cura Integrative Medicine, and Holistic Heal are the top players in global nutrigenomics testing industry space.